Browsing by Author "Odedina, Folakemi"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Abstract 1310: Social determinants of migrant health factors impacting prostate cancer care and survivorship among sub-Saharan African immigrant men diagnosed with prostate cancer
    (Volume 84, Issue 6_Supplement POSTER PRESENTATIONS - PROFFERED ABSTRACTS, 2024-03-15) Kaninjing, Ernest; Asiedu, Gladys; Voorhis, Kaitlin Va; Young, Mary Ellen; Erefah, Ebenezer; Agboola, Emmanuel; Odedina, Folakemi; Dronca, Roxana S.; Ashing, Kimlin; Rotimi, Solomon; Ngufor, Che; Merriweather, Arnola; McCall, John; Hill, Anthony
  • No Thumbnail Available
    Item
    Abstract 819: Feasibility of patient centered home care (PCHC) to reduce disparities in high-risk black men with advanced prostate cancer
    (Volume 84, Issue 6_Supplement POSTER PRESENTATIONS - PROFFERED ABSTRACTS, 2024-03-15) Dronca, Roxana S.; Odedina, Folakemi; Ngufor, Che; Ashing, Kimlin; Kaninjing, Ernest; Rotimi, Solomon
    The objective of our study is to evaluate the feasibility, acceptance, and impact of patient-centered home care (PCHC) on patient reported outcomes (PROs) and health related quality of life (HQoL) of black men with advanced prostate cancer (CaP). Meeting patients where they are and offering treatment in or closer to their homes reduce psychological distress and increase treatment compliance, especially for disadvantaged patients in rural areas, those on low incomes, with poor access to transport, elderly and people with disabilities. In 2023, Mayo Clinic has developed the Cancer Care Beyond Walls (CCBW) program, a cancer care delivery model that integrates virtual with in facility treatment and provides a package of care to support administration of cancer-directed therapy (chemotherapy, immunotherapy, hormonal therapy) and/or supportive care in the patients’ homes. Our study will assess if patients and families are comfortable with cancer therapy at home, what factors influences their decision, and use this data to inform our understanding of the proportion of the black men with advanced CaP who would be willing to receive and would benefit from this level of care at home. Patients with advanced CaP from our practice requiring active anti-cancer therapy are administered a brief questionnaire regarding preference for location of therapy at the infusion center or in the home, with perceived difficulties and advantages of each approach. A focus group session with prostate cancer survivor advocates is also conducted to capture patients’ thoughts, feelings, attitudes, and questions towards cancer treatments being administered at home versus a hospital setting. In addition, we are conducting an observational study of 20 patients with advanced prostate cancer receiving supportive care/symptom management and/or anti cancer therapy in the home as part of the Mayo Clinic CCBW Program to assess the safety of cancer directed therapy when administered at home by a home health provider with remote patient monitoring and command center support, and establish the impact of home cancer treatment administration on patient-reported function and global health/quality of life, patient-reported symptoms, clinical outcomes, and cost of care. Successful completion of the project will deliver data on patient understanding and acceptability of cancer care at home, strategies for overcoming barriers to care for underserved communities, and the foundation from which we discover, translate and apply new knowledge in administering personalized care to vulnerable populations.